Upvote
Downvote
Director, Early Value Lead - Oncology
Share Job
- Suggest Revision
$289,000 a year
Full-time
- The eVL will do this by executing pricing research, market access assessments, defining optimized launch sequencing and co-development of payor value propositions that illustrate the value of the product.
- The role will require leadership to ensure Value perspectives from the US market are incorporated into deliverables such as the Asset Evidence Plan, Target Product Profile (TPP) and Integrated Asset Plan (IAP) and that those perspectives brought forward to corporate colleagues then drive co-creation of the early asset development strategy with the Global Asset Team.
- They will be responsible for collaborating with multiple functional groups as part of their knowledge network, including but not limited to Marketing, Medical, Clinical Development, HEOR, Regulatory, Finance, Competitive Intelligence, Forecasting, Analytics, and Insights, Legal, Public Policy and Global Market Access teams, to define and execute on asset team strategic and operational deliverables.
- Develops indication specific US Early Value Strategies for assigned therapeutic areas containing early pricing, market access, optimized launch sequencing and payor value proposition strategy and including payer insights with IRA considerations to optimize likelihood of success for assets and indications in the U.S. Market
- Leads pricing strategy efforts for BIPI, in coordination with Corporate Market Access colleagues, including testing of eTPPs, understanding volume and access trade-offs and inclusion of receptivity and expectations among stakeholders to engage in innovative contracting strategies to inform forecasting assumptions
Active Job
Updated 24 days agoSimilar Job
Relevance
Active